A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/44 (2006.01) A61K 31/00 (2006.01) A61K 31/425 (2006.01) A61K 31/426 (2006.01) A61K 31/427 (2006.01) A61K 31/4439 (2006.01)
Patent
CA 2260044
A method for the treatment and/or prophylaxis of leptin resistance and/or conditions associated with leptin resistance and/or complications thereof, in humans or non-human mammals, which method comprises the internal administration of an effective, non-toxic and pharmaceutically acceptable amount of a leptin sensitiser or a pharmaceutically acceptable derivative thereof.
L'invention concerne un procédé de traitement et/ou de prophylaxie contre la résistance à la leptine et/ou d'états associés à la résistance à la leptine, et/ou de complications affectant des mammifères humains ou non humains. Ce procédé consiste à administrer par voie interne une quantité efficace, non toxique et pharmaceutiquement acceptable d'un sensibilisant à la leptine ou d'un dérivé pharmaceutiquement acceptable de celle-ci.
Poste George Henry
Smith Stephen Alistair
Gowling Lafleur Henderson Llp
Smithkline Beecham P.l.c.
LandOfFree
Novel treatment of leptine resistance does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel treatment of leptine resistance, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel treatment of leptine resistance will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1891979